BR112016008956A2 - Detecção de atividade de clivagem de uma enzima - Google Patents

Detecção de atividade de clivagem de uma enzima

Info

Publication number
BR112016008956A2
BR112016008956A2 BR112016008956A BR112016008956A BR112016008956A2 BR 112016008956 A2 BR112016008956 A2 BR 112016008956A2 BR 112016008956 A BR112016008956 A BR 112016008956A BR 112016008956 A BR112016008956 A BR 112016008956A BR 112016008956 A2 BR112016008956 A2 BR 112016008956A2
Authority
BR
Brazil
Prior art keywords
enzyme
detection
cleavage activity
enzyme cleavage
activity
Prior art date
Application number
BR112016008956A
Other languages
English (en)
Portuguese (pt)
Inventor
Davis Paul
Parekh Gita
SCHOUTEN James
Original Assignee
Mologic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mologic Ltd filed Critical Mologic Ltd
Publication of BR112016008956A2 publication Critical patent/BR112016008956A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/382Cystic fibrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
BR112016008956A 2013-10-23 2014-10-23 Detecção de atividade de clivagem de uma enzima BR112016008956A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201318728A GB201318728D0 (en) 2013-10-23 2013-10-23 Detection of cleavage activity of an enzyme
PCT/GB2014/053171 WO2015059487A2 (en) 2013-10-23 2014-10-23 Detection of cleavage activity of an enzyme

Publications (1)

Publication Number Publication Date
BR112016008956A2 true BR112016008956A2 (pt) 2017-09-19

Family

ID=49727217

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016008956A BR112016008956A2 (pt) 2013-10-23 2014-10-23 Detecção de atividade de clivagem de uma enzima

Country Status (11)

Country Link
US (2) US10866236B2 (https=)
EP (1) EP3060915B1 (https=)
JP (1) JP6496322B2 (https=)
CN (1) CN105940304B (https=)
AU (1) AU2014338709B2 (https=)
BR (1) BR112016008956A2 (https=)
CA (1) CA2928308C (https=)
GB (1) GB201318728D0 (https=)
MX (1) MX371379B (https=)
RU (1) RU2016119422A (https=)
WO (1) WO2015059487A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201605110D0 (en) 2016-03-24 2016-05-11 Mologic Ltd Detecting sepsis
AU2017248354A1 (en) * 2016-04-08 2018-10-04 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
CN110268054A (zh) * 2016-11-16 2019-09-20 通用生物传感器有限公司 切割事件转导方法和产品
WO2019043187A1 (en) * 2017-08-31 2019-03-07 Somaprobes Sl SIDE FLOW ASSAY FOR DETECTING THE PRESENCE OF A MAMMALIAN CELL OR SPECIFIC BACTERIUM IN A BIOLOGICAL SAMPLE
EP3692146A4 (en) * 2017-10-04 2021-06-30 The Broad Institute, Inc. DIAGNOSTICS BASED ON CRISPR EFFECTOR SYSTEM
US11732009B2 (en) * 2018-06-08 2023-08-22 Glympse Bio, Inc. Activity sensor with tunable analyte
GB201812331D0 (en) * 2018-07-27 2018-09-12 Mologic Ltd Bacterial vaginosis diagnostic
BR112021012036A2 (pt) * 2018-12-20 2021-09-21 Takeda Pharmaceutical Company Limited Novas sondas baseadas em atividade para elastase neutrofílica e seu uso
EP4211468A4 (en) 2020-09-11 2024-10-09 Glympse Bio, Inc. DETECTION OF EX VIVO PROTEASE ACTIVITY FOR DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT OF DISEASES

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795702A (en) 1986-02-05 1989-01-03 Immunogon Associates Diagnostic method for gonorrhea by assay of IgA1 fragments
WO2003102544A2 (en) 2002-05-31 2003-12-11 Cognosci, Inc. Assays for measuring matrix metalloproteinase activities
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
WO2004099784A2 (en) * 2003-05-06 2004-11-18 Anamar Medical Ab Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
GB0311961D0 (en) 2003-05-23 2003-06-25 Health Prot Agency Mass-based toxin assay and substrates therefor
WO2005024050A1 (en) 2003-09-10 2005-03-17 Antibodyshop A/S Analytical methods for determination of proteolytic cleavage at specific sites
EP1792181B1 (en) * 2004-06-21 2010-11-17 Progenra Inc. Diagnostic and screening methods and kits associated with proteolytic activity
CN101180405A (zh) 2005-05-20 2008-05-14 株式会社三菱化学药得论 酶分析方法
GB2435511A (en) * 2006-02-23 2007-08-29 Mologic Ltd Protease detection
GB2437311A (en) * 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
US7897360B2 (en) * 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
EP2712423A4 (en) 2011-02-25 2015-06-10 Wellstat Diagnostics Llc Assays for detecting enzymatic activity
WO2013116791A1 (en) 2012-02-02 2013-08-08 Mosaic Biosciences, Inc. Biomaterials for delivery of blood extracts and methods of using same
GB201206976D0 (en) 2012-04-20 2012-06-06 Mologic Ltd An enzyme detection device

Also Published As

Publication number Publication date
CA2928308C (en) 2023-07-11
GB201318728D0 (en) 2013-12-04
JP6496322B2 (ja) 2019-04-03
WO2015059487A3 (en) 2015-09-17
US20160238596A1 (en) 2016-08-18
RU2016119422A (ru) 2017-11-28
US20200378963A1 (en) 2020-12-03
EP3060915A2 (en) 2016-08-31
WO2015059487A2 (en) 2015-04-30
US10866236B2 (en) 2020-12-15
US12320804B2 (en) 2025-06-03
EP3060915B1 (en) 2018-12-05
AU2014338709B2 (en) 2020-06-25
MX2016005313A (es) 2017-03-01
CN105940304B (zh) 2019-09-13
JP2016535282A (ja) 2016-11-10
AU2014338709A1 (en) 2016-06-02
CN105940304A (zh) 2016-09-14
CA2928308A1 (en) 2015-04-30
MX371379B (es) 2020-01-28

Similar Documents

Publication Publication Date Title
BR112016008956A2 (pt) Detecção de atividade de clivagem de uma enzima
BR112016010510A2 (pt) método, arranjo e uso do mesmo
BR112013025024A2 (pt) sistema para análise química quantitativa de amostras, em particular no campo médico, com calibragem da resposta instrumental da instrumentação usada para detectar os dados quantitativos dos analitos presentes nas amostras analisadas e o método correspondente
BR112014031509B8 (pt) Método para a determinação simultânea in vitro em tempo real do curso da atividade da enzima proteolítica e da resistência do coágulo de fibrina, reômetro rotativo e uso de um reômetro rotativo
BR112015009932A8 (pt) métodos
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
BR112014011818A2 (pt) método para realizar ensaios de quantificação
MX366275B (es) Metodos para detectar y medir la agregacion.
ES2570380T3 (es) Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento
BR112016029634A2 (pt) kit, dispositivo e método para a detecção de câncer de fígado
CO6680668A2 (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
BR112017007163A2 (pt) sistema e métodos para medição do teor de gás em fluidos de perfuração.
BR112013021590A2 (pt) detecção de capacitância em ensaio eletroquímico com resposta otimizada
BR112015018434A2 (pt) método, e, conjunto para medir uma vitamina d
BR112013007156A2 (pt) sistemas e métodos para estabilidade aperfeiçoada de sensores eletroquímicos
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
IN2014DE01077A (https=)
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
GB201206977D0 (en) An enzyme detection device
PE20141450A1 (es) Ensayo de lisiloxidasa-homologo 2 y metodos de uso del mismo
MX2016013462A (es) Metodos y dispositivos para deteccion de resistencia a un inhibidor de enzima.
BR112019006731A2 (pt) sistema de análise para testagem de uma amostra
BR112016002237A2 (pt) método e sistema para determinação precisa da posição de cabos instrumentados
BR112012021411A2 (pt) mutações braf que conferem resistência a inibidores braf.
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]